FDA expands Pfizer booster shots to 16- and 17-year-olds
UNITED STATES – The U.S. is expanding COVID-19 boosters to 16 and 17-year-olds.
The FDA gave the emergency authorization on Thursday for 16 and 17-year-olds to get a third dose of the Pfizer vaccine if it’s been six months since their last shot. Now, the CDC must formally recommend the boosters for this age group. We’re told a decision is expected soon.
The Pfizer vaccine is the only option in the U.S. for anyone younger than 18, either for initial vaccination or for use as a booster. It is not clear yet if or when teens younger than 16 might need a third Pfizer dose.
Vaccinations for children age 5 to 11 began last month. As of this week, roughly 5 million 5 to 11-year-olds had gotten a first dose.